UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Amyloid Beta in Aging and Alzheimer's Disease

International journal of molecular sciences, 2022-10, Vol.23 (21), p.12924

2022

Volltextzugriff (PDF)

Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance

Biochimica et biophysica acta. Molecular basis of disease, 2020-04, Vol.1866 (4), p.165339-165339, Article 165339

2020

Volltextzugriff (PDF)

Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer's disease

Human molecular genetics, 2018-07, Vol.27 (14), p.2502-2516

2018

Volltextzugriff (PDF)

Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease

Biochimica et biophysica acta. Molecular basis of disease, 2019-09, Vol.1865 (9), p.2428-2440

2019

Volltextzugriff (PDF)

Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer's Disease

Frontiers in aging neuroscience, 2020-01, Vol.11, p.369-369

2020

Volltextzugriff (PDF)

The Role of Obesity and Diabetes in Dementia

International journal of molecular sciences, 2022-08, Vol.23 (16), p.9267

2022

Volltextzugriff (PDF)

Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: Implications to mitochondria-targeted antioxidant therapeutics

Biochimica et biophysica acta, 2012-05, Vol.1822 (5), p.639-649

2012

Volltextzugriff (PDF)

Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection

Molecular neurobiology, 2020-11, Vol.57 (11), p.4856-4877

2020

Volltextzugriff (PDF)

Corrigendum to ‘Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease’ [Pharmacol Res. 174 (2021) 105973]

Pharmacological research, 2024-04, Vol.202, p.107134-107134, Article 107134

2024

Volltextzugriff (PDF)

COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges

Cells (Basel, Switzerland), 2021-11, Vol.10 (12), p.3291

2021

Volltextzugriff (PDF)

Current Status of Obesity: Protective Role of Catechins

Antioxidants, 2023-02, Vol.12 (2), p.474

2023

Volltextzugriff (PDF)

Therapeutics of Alzheimer's Disease: Recent Developments

Antioxidants, 2022-12, Vol.11 (12), p.2402

2022

Volltextzugriff (PDF)

Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases

Biomedical Journal, 2022-10, Vol.45 (5), p.733-748

2022

Volltextzugriff (PDF)

Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer’s disease

Human molecular genetics, 2021-05, Vol.30 (10), p.847-864

2021

Volltextzugriff (PDF)

Effects of obesogenic diet and estradiol on dorsal raphe gene expression in old female macaques

PloS one, 2017-06, Vol.12 (6), p.e0178788-e0178788

2017

Volltextzugriff (PDF)

Support Provided by Caregivers for Community-Dwelling Obesity Individuals: Focus on Elderly and Hispanics

Healthcare (Basel), 2023-05, Vol.11 (10), p.1442

2023

Volltextzugriff (PDF)

Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease

Pharmacological research, 2021-12, Vol.174, p.105973-105973, Article 105973

2021

Volltextzugriff (PDF)

Protective effects of mitophagy enhancers against amyloid beta-induced mitochondrial and synaptic toxicities in Alzheimer disease

Human molecular genetics, 2022-02, Vol.31 (3), p.423-439

2022

Volltextzugriff (PDF)

Neural regeneration therapies for Alzheimer's and Parkinson's disease-related disorders

Biochimica et biophysica acta. Molecular basis of disease, 2020-04, Vol.1866 (4), p.165506-165506, Article 165506

2020

Volltextzugriff (PDF)

A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease

Cells (Basel, Switzerland), 2022-08, Vol.11 (17), p.2660

2022

Volltextzugriff (PDF)

Rlip Reduction Induces Oxidative Stress and Mitochondrial Dysfunction in Mutant Tau-Expressed Immortalized Hippocampal Neurons: Mechanistic Insights

Cells (Basel, Switzerland), 2023-06, Vol.12 (12), p.1646

2023

Volltextzugriff (PDF)

Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse

Free radical biology & medicine, 2021-08, Vol.172, p.652-667

2021

Volltextzugriff (PDF)

Protective effects of SSRI, Citalopram in mutant APP and mutant Tau expressed dorsal raphe neurons in Alzheimer's disease

Biochimica et biophysica acta. Molecular basis of disease, 2024-02, Vol.1870 (2), p.166942-166942, Article 166942

2024

Volltextzugriff (PDF)

Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer's Disease

Cells (Basel, Switzerland), 2022-02, Vol.11 (4), p.733

2022

Volltextzugriff (PDF)

Correction: Reddy et al. Rlip Reduction Induces Oxidative Stress and Mitochondrial Dysfunction in Mutant Tau-Expressed Immortalized Hippocampal Neurons: Mechanistic Insights. Cells 2023, 12 , 1646

Cells (Basel, Switzerland), 2024-01, Vol.13 (2), p.145

2024

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(104)

Sprache

Englisch
(104)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Amyloid Beta in Aging and Alzheimer's Disease

Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance

Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer's disease

Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease

Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer's Disease

The Role of Obesity and Diabetes in Dementia

Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: Implications to mitochondria-targeted antioxidant therapeutics

Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection

Corrigendum to ‘Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease’ [Pharmacol Res. 174 (2021) 105973]

COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges

Current Status of Obesity: Protective Role of Catechins

Therapeutics of Alzheimer's Disease: Recent Developments

Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases

Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer’s disease

Effects of obesogenic diet and estradiol on dorsal raphe gene expression in old female macaques

Support Provided by Caregivers for Community-Dwelling Obesity Individuals: Focus on Elderly and Hispanics

Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease

Protective effects of mitophagy enhancers against amyloid beta-induced mitochondrial and synaptic toxicities in Alzheimer disease

Neural regeneration therapies for Alzheimer's and Parkinson's disease-related disorders

A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease

Rlip Reduction Induces Oxidative Stress and Mitochondrial Dysfunction in Mutant Tau-Expressed Immortalized Hippocampal Neurons: Mechanistic Insights

Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse

Protective effects of SSRI, Citalopram in mutant APP and mutant Tau expressed dorsal raphe neurons in Alzheimer's disease

Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer's Disease

Correction: Reddy et al. Rlip Reduction Induces Oxidative Stress and Mitochondrial Dysfunction in Mutant Tau-Expressed Immortalized Hippocampal Neurons: Mechanistic Insights. Cells 2023, 12 , 1646

Suchergebnisse filtern